Literature DB >> 22772551

NKT cells--an early warning system for HBV infection.

Dale I Godfrey, Adam P Uldrich, Alan G Baxter.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22772551     DOI： 10.1038/nm.2853

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

Review 1.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

Review 2.  Going both ways: immune regulation via CD1d-dependent NKT cells.

Authors:  Dale I Godfrey; Mitchell Kronenberg
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

3.  Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus.

Authors:  Federica Facciotti; Gundimeda S Ramanjaneyulu; Marco Lepore; Sebastiano Sansano; Marco Cavallari; Magdalena Kistowska; Sonja Forss-Petter; Guanghui Ni; Alessia Colone; Amit Singhal; Johannes Berger; Chengfeng Xia; Lucia Mori; Gennaro De Libero
Journal:  Nat Immunol       Date:  2012-03-18       Impact factor: 25.606

Review 4.  Hepatitis B virus infection, its sequelae, and prevention by vaccination.

Authors:  Li-Min Huang; Chun-Yi Lu; Ding-Shinn Chen
Journal:  Curr Opin Immunol       Date:  2011-01-21       Impact factor: 7.486

5.  Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection.

Authors:  Jody L Baron; Leon Gardiner; Stephen Nishimura; Kanade Shinkai; Richard Locksley; Don Ganem
Journal:  Immunity       Date:  2002-04       Impact factor: 31.745

Review 6.  Immunobiology and pathogenesis of viral hepatitis.

Authors:  Luca G Guidotti; Francis V Chisari
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

7.  Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial.

Authors:  Andrea M Woltman; Martijn J Ter Borg; Rekha S Binda; Dave Sprengers; B Mary E von Blomberg; Rik J Scheper; Kunihiko Hayashi; Nobusuke Nishi; André Boonstra; Renate van der Molen; Harry L A Janssen
Journal:  Antivir Ther       Date:  2009

8.  Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity.

Authors:  Sebastian Zeissig; Kazumoto Murata; Lindsay Sweet; Jean Publicover; Zongyi Hu; Arthur Kaser; Esther Bosse; Jahangir Iqbal; M Mahmood Hussain; Katharina Balschun; Christoph Röcken; Alexander Arlt; Rainer Günther; Jochen Hampe; Stefan Schreiber; Jody L Baron; D Branch Moody; T Jake Liang; Richard S Blumberg
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

9.  Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B.

Authors:  Xiaotao Jiang; Mingxia Zhang; Qintao Lai; Xuan Huang; Yongyin Li; Jian Sun; William G H Abbott; Shiwu Ma; Jinlin Hou
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

10.  Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells.

Authors:  Stephanie K Dougan; Azucena Salas; Paul Rava; Amma Agyemang; Arthur Kaser; Jamin Morrison; Archana Khurana; Mitchell Kronenberg; Caroline Johnson; Mark Exley; M Mahmood Hussain; Richard S Blumberg
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307
View more
  3 in total

1.  Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.

Authors:  Zhuo Wang; Kai Zhu; Weiya Bai; Baosen Jia; Hao Hu; Dongming Zhou; Xiaoming Zhang; Xinxin Zhang; Youhua Xie; Maryline Mancini Bourgine; Marie-Louise Michel; Ke Lan; Qiang Deng
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

Review 2.  Natural Killer T Cells in Various Mouse Models of Hepatitis.

Authors:  Jun Guan; Gang Wang; Qin Yang; Chao Chen; Jingwen Deng; Xinyu Gu; Haihong Zhu
Journal:  Biomed Res Int       Date:  2021-01-06       Impact factor: 3.411

Review 3.  CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil".

Authors:  Günther Schönrich; Martin J Raftery
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.